Jul 5, 2022 | GSK, Member News, Stevenage Bioscience Catalyst
Further plans for Stevenage campus expansion sharedDeveloper partners announced as Reef Group and UBS Asset ManagementGSK to gift land to SBC to enable expansion Stevenage Bioscience Catalyst (SBC) is based on the life science campus in Stevenage, Hertfordshire....
Mar 2, 2022 | Member News, Stevenage Bioscience Catalyst
DATA accelerator programme launches for data-enabled drug discovery, genomics and advanced therapies start-upsIntroductions to investors, plus mentoring, skills training and networking£10,000 award for the start-up with the best pitch Stevenage Bioscience Catalyst...
Jan 5, 2022 | Stevenage Bioscience Catalyst
An independent report has been released by Stevenage Bioscience Catalyst (SBC) that demonstrates its key role in delivering economic benefit from life sciences research and innovation in the UK. SBC was formed in 2012 through a collaboration between the Department for...
Nov 18, 2021 | Member News, Stevenage Bioscience Catalyst
Pictured left to right: Dr Hugo Villanueva (SBC), Dr Ajay Mistry (founder and CEO of Oppilotech Ltd) and Dr Sally Ann Forsyth OBE (CEO of SBC) 15 start-ups with huge potential have successfully completed the Data-driven Advanced Therapeutics Accelerator (DATA)...
Jul 16, 2021 | GSK, Member News, Sector News, Stevenage Bioscience Catalyst
GSK has announced that it has formally started the process of seeking a development partner to transform land within the company’s existing 92-acre Research & Development site in Stevenage into one of Europe’s largest ‘clusters’ for biotechnology and other...
Feb 24, 2021 | Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst (SBC) has launched a free accelerator programme to give data-focussed biotech start-ups the skills they need to get potential new drugs and therapies to market more quickly. The programme will run from May and is aimed at supporting...
